October 28, 2011
In its consolidated settlement of accounts for January-September 2011 announced on October 27, Kyowa Hakko Kirin’s pharmaceutical business posted sales of ¥168,200 million (+9.2% compared to the corresponding period of the previous year), and operating profits of ¥33,100 million (+25.1%)...read more